We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$123M
AUM Growth
+$6.83M
Cap. Flow
+$5.77M
Cap. Flow %
4.71%
Top 10 Hldgs %
30.09%
Holding
83
New
2
Increased
48
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.18M
2
DIS icon
Walt Disney
DIS
+$1.26M
3
BWA icon
BorgWarner
BWA
+$929K
4
MCK icon
McKesson
MCK
+$698K
5
FDX icon
FedEx
FDX
+$652K

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$3.49M
2
PEP icon
PepsiCo
PEP
+$925K
3
CVX icon
Chevron
CVX
+$857K
4
KR icon
Kroger
KR
+$680K
5
OXY icon
Occidental Petroleum
OXY
+$534K

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.09%
2 Healthcare 20.88%
3 Technology 16.15%
4 Industrials 11.92%
5 Materials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNPR
51
DELISTED
Juniper Networks
JNPR
$381K 0.31%
10,245
-1,303
-11% -$44.8K
SLB icon
52
SLB Ltd
SLB
$73.3B
$381K 0.31%
9,225
-1,570
-15% -$61.5K
PG icon
53
Procter & Gamble
PG
$339B
$379K 0.31%
1,239
-1,004
-45% -$157K
KEX icon
54
Kirby Corp
KEX
$7.04B
$368K 0.3%
5,095
-1,275
-20% -$85K
UVV icon
55
Universal Corp
UVV
$1.31B
$359K 0.29%
6,178
+695
+13% +$38.3K
MOS icon
56
The Mosaic Company
MOS
$6.98B
$354K 0.29%
5,330
-3,181
-37% -$159K
AVNS
57
DELISTED
Avanos Medical
AVNS
$352K 0.29%
10,510
+2,745
+35% +$88.4K
DAN icon
58
Dana Inc
DAN
$2.94B
$346K 0.28%
19,707
+3,267
+20% +$66.8K
SXI icon
59
Standex International
SXI
$3.74B
$345K 0.28%
2,255
-1,054
-32% -$110K
GHC icon
60
Graham Holdings Company
GHC
$5.15B
$344K 0.28%
562
+71
+14% +$42.6K
FLO icon
61
Flowers Foods
FLO
$1.49B
$342K 0.28%
13,300
+1,265
+11% +$34.4K
OXY icon
62
Occidental Petroleum
OXY
$55.5B
$335K 0.27%
5,898
-12,072
-67% -$534K
RPM icon
63
RPM International
RPM
$14B
$331K 0.27%
3,317
+28
+0.9% +$2.4K
DGP icon
64
DB Gold Double Long ETN due February 15, 2038
DGP
$215M
$329K 0.27%
7,500
MCK icon
65
McKesson
MCK
$100B
$314K 0.26%
3,806
+2,567
+207% +$698K
LNG icon
66
Cheniere Energy
LNG
$54.5B
$286K 0.23%
2,065
-168
-8% -$20.4K
MLM icon
67
Martin Marietta Materials
MLM
$32.4B
$279K 0.23%
725
-393
-35% -$152K
NI icon
68
NiSource
NI
$21.5B
$278K 0.23%
8,752
+375
+4% +$10.9K
XOM icon
69
ExxonMobil
XOM
$642B
$269K 0.22%
3,304
-502
-13% -$39K
ROK icon
70
Rockwell Automation
ROK
$53.9B
$267K 0.22%
955
-444
-32% -$128K
LFCR icon
71
Lifecore Biomedical
LFCR
$167M
$263K 0.21%
22,745
+4,790
+27% +$53.3K
HSII
72
DELISTED
Heidrick & Struggles
HSII
$260K 0.21%
6,562
+1,365
+26% +$57.7K
XYL icon
73
Xylem
XYL
$27.9B
$250K 0.2%
2,932
+970
+49% +$92.9K
CTXS
74
DELISTED
Citrix Systems Inc
CTXS
$250K 0.2%
2,475
+200
+9% +$20.2K
RL icon
75
Ralph Lauren
RL
$22.6B
$245K 0.2%
2,161
+335
+18% +$39.5K

Similar funds

Keene & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Keene & Associates held 83 positions worth $123M, up 5.9% from $116M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Keene & Associates deployed $5.77M of net new capital in Q1 2022, opening 2 new positions and adding to 48 existing holdings. Its largest new stake was Medtronic: 30,074 shares worth $3.34M.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was PepsiCo, an estimated $925K trimmed.

  • Keene & Associates's largest Q1 2022 buy was Medtronic: 30,074 shares worth $3.34M.
  • Keene & Associates added most to Walt Disney in Q1 2022, an estimated $1.26M increase.
  • Keene & Associates's biggest Q1 2022 reduction was PepsiCo, cutting an estimated $925K.
  • Keene & Associates fully exited Exelon in Q1 2022, selling an estimated $3.49M.
  • Keene & Associates's ten largest holdings make up 30% of its $123M portfolio in Q1 2022.
  • Keene & Associates opened 2 new positions and closed 2 in Q1 2022.
  • Keene & Associates's portfolio value rose 5.9% quarter-over-quarter to $123M.

Based on Keene & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.